✦ LIBER ✦

Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of

✍ Scribed by Jean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, Pere Gascon, Carsten Bokemeyer, Heinz Ludwig, Jan Vermorken, Jason Legg, Beatriz Pujol, Ken Bridges

Book ID: 118821494
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 330 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-011-0103-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemoglobin level at initiation of darbep

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe

✍ Melike Deger, Wolfgang Eisterer, Lucie Kutikova, Sam Salek 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Darbepoetin alfa for treating chemothera

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

✍ Johan Vansteenkiste; Michael Hedenus; Pere Gascon; Carsten Bokemeyer; Heinz Ludw 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 751 KB

1120 POSTER Evaluation of the associatio

1120 POSTER Evaluation of the association between hemoglobin (Hb) events and safety outcomes in cancer patients (pts) with chemotherapy-induced anemia (CIA): an integrated analysis of patient-level data from 6 randomized, placebo-controlled trials (RCTs) of darbepoetin alfa (DA)

✍ J. Glaspy; A. Österborg; H. Ludwig; A. Fleishman; T. Lillie; T. Süto; J. Crawfor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB